Cite
Can biomarkers identified from the uterine fluid transcriptome be used to establish a noninvasive endometrial receptivity prediction tool? A proof-of-concept study.
MLA
He, Aihua, et al. “Can Biomarkers Identified from the Uterine Fluid Transcriptome Be Used to Establish a Noninvasive Endometrial Receptivity Prediction Tool? A Proof-of-Concept Study.” Reproductive Biology & Endocrinology, vol. 21, no. 1, Feb. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12958-023-01070-0.
APA
He, A., Wu, H., Zou, Y., Wan, C., Zhao, J., Zhang, Q., Liu, N., Liu, D., Li, Y., Fu, J., Li, H., Huang, X., Yang, T., Hu, C., Hou, Z., Sun, Y., Dong, X., Wu, J., Lu, S., & Li, Y. (2023). Can biomarkers identified from the uterine fluid transcriptome be used to establish a noninvasive endometrial receptivity prediction tool? A proof-of-concept study. Reproductive Biology & Endocrinology, 21(1), 1–15. https://doi.org/10.1186/s12958-023-01070-0
Chicago
He, Aihua, Hong Wu, Yangyun Zou, Cheng Wan, Jing Zhao, Qiong Zhang, Nenghui Liu, et al. 2023. “Can Biomarkers Identified from the Uterine Fluid Transcriptome Be Used to Establish a Noninvasive Endometrial Receptivity Prediction Tool? A Proof-of-Concept Study.” Reproductive Biology & Endocrinology 21 (1): 1–15. doi:10.1186/s12958-023-01070-0.